{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:36:41Z","timestamp":1792654601419,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.mayocp.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T04:34:34Z","timestamp":1435725274000},"page":"940-951","source":"Crossref","is-referenced-by-count":230,"title":["Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management"],"prefix":"10.1016","volume":"90","author":[{"given":"James C.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. James B.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mayocp.2012.08.020","article-title":"Why patients visit their doctors: assessing the most prevalent conditions in a defined American population","volume":"88","author":"St Sauver","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2015.05.004_bib2","first-page":"1","article-title":"National Ambulatory Medical Care Survey: 2007 summary","volume":"27","author":"Hsiao","year":"2010","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.mayocp.2015.05.004_bib3","unstructured":"Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey factsheet: neurology. Centers for Disease Control and Prevention website. http:\/\/www.cdc.gov\/nchs\/data\/ahcd\/NAMCS_2010_factsheet_neurology.pdf. Accessed May 13,\u00a02015."},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.004_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Martyn","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.mayocp.2015.05.004_bib5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1212\/WNL.45.10.1832","article-title":"Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions, I: Prevalence and general characteristics of the sample","volume":"45","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diaclin.23.1.9","article-title":"Management of diabetic peripheral neuropathy","volume":"23","author":"Boulton","year":"2005","journal-title":"Clin Diabetes"},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.004_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.004_bib9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.27.7.1591","article-title":"Prevalence of lower-extremity disease in the US adult population \u226540 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey","volume":"27","author":"Gregg","year":"2004","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.05.004_bib10","first-page":"S14","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.004_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","article-title":"Comprehensive foot examination and risk assessment: a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists","volume":"31","author":"Boulton","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8227(01)00278-9","article-title":"Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic","volume":"54","author":"Olaleye","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdiacomp.2003.12.006","article-title":"Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening","volume":"19","author":"Kamei","year":"2005","journal-title":"J\u00a0Diabetes Complications"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.12816\/0005988","article-title":"Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in primary health care setting","volume":"6","author":"Al-Geffari","year":"2012","journal-title":"Int J Health Sci (Qassim)"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archinte.158.3.289","article-title":"Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration","volume":"158","author":"Armstrong","year":"1998","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.004_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.004_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archneur.1994.00540180051013","article-title":"Comparison of neurologic changes in 'successfully aging' persons vs the total aging population","volume":"51","author":"Odenheimer","year":"1994","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archinternmed.2011.1032","article-title":"Tests and expenditures in the initial evaluation of peripheral neuropathy","volume":"172","author":"Callaghan","year":"2012","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.004_bib21","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc05-2228","article-title":"The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes","volume":"29","author":"Davies","year":"2006","journal-title":"Diabetes Care"},{"issue":"4, suppl","key":"10.1016\/j.mayocp.2015.05.004_bib22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0025-6196(11)61474-2","article-title":"Diabetic peripheral neuropathic pain: clinical and quality-of-life issues","volume":"81","author":"Argoff","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","article-title":"Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics","volume":"35","author":"Van Acker","year":"2009","journal-title":"Diabetes Metab"},{"issue":"14","key":"10.1016\/j.mayocp.2015.05.004_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2015.05.004_bib25","first-page":"CD009122","article-title":"Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus","volume":"2","author":"Fullerton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocp.2015.05.004_bib26","first-page":"CD008143","article-title":"Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus","volume":"11","author":"Hemmingsen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.004_bib27","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/WNL.53.9.2113","article-title":"Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy","volume":"53","author":"Dyck","year":"1999","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.004_bib28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.24.8.1448","article-title":"Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy","volume":"24","author":"Singleton","year":"2001","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.004_bib29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mus.1136","article-title":"Painful sensory polyneuropathy associated with impaired glucose tolerance","volume":"24","author":"Singleton","year":"2001","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.004_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/diab.36.6.730","article-title":"Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance","volume":"36","author":"Fujimoto","year":"1987","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2337\/dc11-1421","article-title":"Impaired glycemia and diabetic polyneuropathy: the OC IG Survey","volume":"35","author":"Dyck","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJMcp1113996","article-title":"Vitamin B12 deficiency","volume":"368","author":"Stabler","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.004_bib34","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.004_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.164.9.1021","article-title":"The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy","volume":"164","author":"Smith","year":"2004","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.004_bib36","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.004_bib37","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/clinchem\/34.8.1633","article-title":"Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum","volume":"34","author":"Kahn","year":"1988","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archneur.60.2.260","article-title":"Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness","volume":"60","author":"Mygland","year":"2003","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.004_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","article-title":"Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP","volume":"83","author":"Mauermann","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.mayocp.2015.05.004_bib42","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/01.WNL.0000063307.84039.C7","article-title":"Celiac neuropathy","volume":"60","author":"Chin","year":"2003","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.mayocp.2015.05.004_bib43","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0000000000000970","article-title":"The neurologic significance of celiac disease biomarkers","volume":"83","author":"McKeon","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/01.WNL.0000132644.52613.FA","article-title":"Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration","volume":"63","author":"Kumar","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.004_bib45","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/01.WNL.0000142038.43946.06","article-title":"A\u00a0controlled study of peripheral neuropathy after bariatric surgery","volume":"63","author":"Thaisetthawatkul","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib46","first-page":"139","article-title":"Medication, toxic, and vitamin-related neuropathies","volume":"18","author":"Morrison","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"9427","key":"10.1016\/j.mayocp.2015.05.004_bib48","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","article-title":"Peripheral neuropathy","volume":"363","author":"England","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-1331.2010.03037.x","article-title":"Genetic epidemiology of Charcot-Marie-Tooth in the general population","volume":"18","author":"Braathen","year":"2011","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.004_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth's disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"issue":"193","key":"10.1016\/j.mayocp.2015.05.004_bib51","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.1111\/ane.12013","article-title":"Genetic epidemiology of Charcot-Marie-Tooth disease","author":"Braathen","year":"2012","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.mayocp.2015.05.004_bib52","first-page":"1208","article-title":"Charcot-Marie-Tooth disease and other inherited neuropathies","volume":"20","author":"Saporta","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.004_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanp\u00e4\u00e4","year":"2011","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib54","first-page":"143","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mayocp.2015.05.004_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/DMSO.S37415","article-title":"Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey","volume":"6","author":"Sadosky","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10, suppl","key":"10.1016\/j.mayocp.2015.05.004_bib56","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"Am J Med"},{"issue":"3, suppl","key":"10.1016\/j.mayocp.2015.05.004_bib57","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.004_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib59","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.004_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"20","key":"10.1016\/j.mayocp.2015.05.004_bib61","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2015.05.004_bib62","first-page":"CD008943","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","volume":"7","author":"Chaparro","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961500378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961500378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T06:54:38Z","timestamp":1599202478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961500378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S002561961500378X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.05.004","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}